The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

Newsletter Oct 2017

Topics include Partnerships with African initiatives, Co-infections and co-morbidities; Research capacity development; Calls & grants. Subscribe here.

Read more

Session at ASTMH

Join the EDCTP (booth 425) & Wellcome Trust symposium on Clinical trials in pregnancy | Session 130 |08/11/2017, 08:00-09:45 |Room 341/342

Symposium programme

Annual Report 2016

“ EDCTP2 is a highly ambitious programme and 2016 was a transformational year for
consolidating the organisation itself and accelerating focused implementation of the programme. ”

Link to download page

Latest news

15 November 2017

EU action against antimicrobial resistance: EDCTP’s contribution

Antimicrobial resistance and improper use of antibiotics are a potential global threat to healthcare. During the European Antibiotic Awareness Week…

Read more
3 November 2017

GSK and EDCTP launch joint call for Senior Fellowship proposals

In response to the growing challenge of non-communicable diseases (NCDs) in Africa, GSK and EDCTP will launch a joint call…

Read more